Myriad Genetics (Nasdaq: MYGN) has acquired Crescendo Bioscience in a $270 million deal. The move helps Myriad move into the autoimmune market. It also adds a mobile and web-based molecular diagnostic platform for rheumatoid arthritis to help patients manage their condition and improve engagement with physicians. It also gives Safeguard (NYSE: SFE) a big exit […]
The shift by Johnson & Johnson (NYSE: JNJ) to provide Yale University School of Medicine’s Open Data Access Project with de-identified data from clinical trials, conceived over a conversation between two Harvard Medical School classmates going for a walk, has huge ramifications for research scientists and patient groups. It also reflects a big change in […]
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.
(Reuters) - PTC Therapeutics Inc said a committee of the European Medicines Agency did not recommend conditional approval of its drug for the treatment of a rare muscular disorder, sending its shares down as much as 28 percent in premarket trading. The...
An Audax Health spokeswoman confirmed that UnitedHealth and Audax were granted approval by the FTC for early termination, an important step in significant merger and acquisition deals. The statement came in response to an emailed request for comment on news that UnitedHealth (NYSE: UHG) is acquiring the digital health company. Katherine Kennedy Allen, Audax Director […]
Despite the regulatory minefield social media poses to pharmaceutical companies, new research from IMS Institute for Healthcare Analytics shows they are raising their social media profiles across Twitter, Facebook and YouTube. Twitter is the social media channel of choice for about half of the 50 largest pharmaceutical companies, followed by YouTube with 17 and Facebook […]
LONDON (Reuters) – Pharmaceuticals company Shire has agreed to sell its Dermagraft treatment to U.S. group Organogenesis, taking a $650 million hit on the loss-making bio-engineered skin substitute it bought less than three years ago. Shire had hoped that Dermagraft would be the foundation of a regenerative medicine franchise when its acquired owner Advanced BioHealing […]
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
In a move that could have a significant impact on how pharmaceutical companies view gamification, Pfizer (NYSE: PFE) has agreed to test the use of a mobile video game from Akili Interactive Labs to detect early signs of Alzheimer’s disease. The goal of the trial is to evaluate Akili’s game as a biomarker for potential […]
Less than one month after NuPathe’s (Nasdaq: PATH) board approved an acquisition offer by Endo Health Solutions, (Nasdaq: ENDP) the specialty pharmaceutical company has unexpectedly found itself at the center of what could be a bidding war after receiving another offer in a surprising development in life science industry news. Big pharma company Teva (NYSE: […]
Medical technology manufacturer Becton Dickinson (NYSE: BDX) has acquired a collaboration partner that produces handheld, electronic diagnostic devices. They are designed to be used at the point of care in places like physician offices, retail clinics and patient homes. The $40 million deal to take over San Jose healthcare technology company Alverix will help it […]
Machines that transmit messages when they need repairs, remote monitoring and reducing hospital acquired infections. Those are a handful of healthcare applications from the growing sector referred to as the Internet of Things. ThingWorx, a Philadelphia area company that is collaborating with several businesses across many sectors, including life science industry companies, is the target of […]
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
The life science industry has been warming up to the use of health IT and digital health tools to improve clinical trials. Remote monitoring, adherence tools and ways to make clinical trial design easier are a few of the areas that have gotten attention. The goal is to cut the time it takes to set […]
There’s been a growing trend among pharmaceutical companies to develop services that can complement or amplify their drug development efforts. In a move that combines that trend with the battle against obesity, Merck (NYSE: MRK) is collaborating with a weight management company in a new division to help people lose weight, according to a company […]
http://www.youtube.com/watch?v=jO_lNh-SCis It’s only been a few months since GlaxoSmithKline (NYSE: GSK) launched a $50 million fund to invest in life science industries developing bioelectronic technology. Now, it has kicked off an innovation challenge to crowdsource the technology. Specifically, it’s looking for an implantable device that can interpret and “write” the body’s electrical signals. Not only […]
Pharmaceutical companies are keen to have a stake in the personalized medicine market, viewed as a growing trend in the future of healthcare and a significant source of life science innovation. As part of that trend, Siemens‘ (NYSE: SI) diagnostics division has agreed to develop companion diagnostics for Pfizer (NYSE: PFE) drugs across therapeutic areas, […]
When it comes to the 25.8 million people with Type 2 diabetes, nonadherence can get expensive. Complications that can be caused by not taking medication properly can produce serious consequences from blindness to amputation. Suffice to say the pressure is on companies to pursue a variety of solutions. Merck (NYSE: MRK) is turning to gamification […]